Product image of Leveraxo (Oxycodone Hydrochloride) supplied by GNH India

Leveraxo

Active Ingredient:
Oxycodone Hydrochloride
Origin:
EU

Leveraxo (Oxycodone Hydrochloride)

Oxycodone, the active ingredient in Leveraxo, is an opioid analgesic presented as an oral formulation for oral use. It treats moderate to severe pain in adult patients requiring prescription opioid therapy. It is indicated for patients with acute postoperative pain, cancer‑related pain, or chronic severe pain where non‑opioid analgesics are insufficient.

GNH India supplies Leveraxo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers.

Manufacturer / TM Owner

Generics [uk] Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Oxycodone, an opioid analgesic, acts on the central nervous system to relieve pain.

  • Moderate to severe acute pain: provides rapid and effective analgesia for short‑term use.
  • Cancer‑related pain: helps control persistent pain associated with malignant disease.
  • Post‑operative pain: reduces pain following surgical procedures to improve recovery.

How It Works

  • Oxycodone hydrochloride binds selectively to mu‑opioid receptors in the brain and spinal cord. Activation of these G‑protein coupled receptors inhibits the release of neurotransmitters involved in nociceptive transmission, decreasing neuronal excitability and altering pain perception. The result is increased pain threshold and reduced response to painful stimuli. These actions are dose‑dependent and contribute to the overall analgesic effect observed in patients.

Side Effects

Oxycodone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: feeling of sickness often accompanied by an urge to vomit.
  • Constipation: reduced bowel movements leading to hard stools.
  • Drowsiness: increased sleepiness or reduced alertness.
  • Dry mouth: reduced salivation causing a parched feeling.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing that can be life‑threatening.
  • Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
  • Addiction or dependence: potential for misuse and physical reliance on the drug.

Precautions & Warnings

When prescribing oxycodone, clinicians should observe several safety considerations to minimize risk.

  • Assess respiratory function: monitor for signs of depression, especially during initiation or dose escalation.
  • Evaluate hepatic and renal function: adjust therapy if significant impairment is present.
  • Avoid concomitant CNS depressants: concurrent use with benzodiazepines, alcohol, or other opioids increases sedation risk.
  • Review patient history for substance abuse: identify risk of dependence or misuse before starting therapy.
  • Pregnancy and lactation: use only if benefits outweigh potential risks to fetus or infant.
  • Store at ambient temperature: keep in original packaging, protect from moisture and heat, and keep out of reach of children.

Avoid Interactions

Oxycodone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Other opioids: additive respiratory depression and sedation.
  • Benzodiazepines: heightened central nervous system depression.
  • Alcohol: potentiates sedative effects and respiratory risk.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): increase oxycodone plasma concentrations.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce analgesic effect.
  • Selective serotonin reuptake inhibitors (SSRIs): may increase risk of serotonin syndrome.

Frequently Asked Questions

Leveraxo contains oxycodone, an opioid analgesic indicated for the management of moderate to severe pain, including acute postoperative pain, cancer‑related pain, and chronic severe pain when non‑opioid treatments are insufficient.

Oxycodone acts as an agonist at mu‑opioid receptors in the central nervous system. By activating these receptors, it inhibits the transmission of pain signals, raises the pain threshold, and alters the perception of painful stimuli.

The dosage of Leveraxo is individualized. A qualified prescriber determines the appropriate strength, frequency, and duration based on the patient’s pain severity, prior opioid exposure, and overall clinical condition.

Safety of oxycodone during pregnancy and lactation has not been fully established. It should be used only when the potential benefit justifies the potential risk to the fetus or infant, and only under close medical supervision.

To order Leveraxo, submit an inquiry on the product page at gnhindia.com, specifying the required quantity and providing institutional credentials. GNH India will verify eligibility and respond with pricing, availability, shipping terms, and any required import documentation.

Leveraxo (oxycodone) provides strong analgesia with a relatively rapid onset compared with morphine, but shares similar risks of respiratory depression, dependence, and constipation. Choice of opioid depends on patient response, clinical context, and formulation considerations.

Store Leveraxo at ambient temperature below 25 °C in its original packaging, protected from moisture, light, and excessive heat. Keep the product out of reach of children and unauthorized persons.

Leveraxo is taken orally, typically as a tablet or capsule, with or without food as directed by the prescribing clinician. The exact administration instructions follow the product labeling and the prescriber’s guidance.

The most serious risks include respiratory depression, profound sedation, severe hypotension, and the potential for addiction, dependence, and overdose. Patients should be closely monitored, especially during therapy initiation or dose adjustments.

Leveraxo is contraindicated in patients with known hypersensitivity to oxycodone, significant respiratory depression, acute severe asthma, paralytic ileus, or those currently taking monoamine oxidase inhibitors. Caution is also advised for individuals with a history of opioid misuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.